Never use anthracyclines with trastuzumab: it is time to reconsider the taboo.
作者信息
Gianni Luca
机构信息
Medical Oncology 1, Istituto dei Tumori di Milano, Via Venezian 1, 20133 Milan, Italy.
出版信息
Breast Cancer Res Treat. 2009 Oct;117(3):599-601. doi: 10.1007/s10549-009-0402-5. Epub 2009 Apr 23.
PMID:19387827
Abstract
摘要
相似文献
1
Never use anthracyclines with trastuzumab: it is time to reconsider the taboo.
Breast Cancer Res Treat. 2009 Oct;117(3):599-601. doi: 10.1007/s10549-009-0402-5. Epub 2009 Apr 23.
2
Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.
Nat Clin Pract Oncol. 2008 Nov;5(11):E1. doi: 10.1038/ncponc1275.
3
Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
J Natl Cancer Inst. 2009 Apr 1;101(7):448-9. doi: 10.1093/jnci/djp072. Epub 2009 Mar 24.
4
Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.
J Natl Cancer Inst. 2013 Jun 19;105(12):835-6. doi: 10.1093/jnci/djt161. Epub 2013 Jun 2.
5
[HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?].
Bull Cancer. 2006 Oct;93(10):991-9.
6
Dose-dense chemotherapy with trastuzumab is an appropriate option.
J Clin Oncol. 2008 Jul 20;26(21):3655-6; author reply 3656. doi: 10.1200/JCO.2008.17.5281.
7
Herceptin: help for advanced breast cancer.
Health News. 2001 May;7(5):4.
8
[Therapy concept: herceptin with anthracyclines].
Onkologie. 2002 Dec;25 Suppl 5:19-21; discussion 21.
9
[Potential risk and benefit of the combination of trastuzumab to chemotherapy and radiation therapy in non-metastatic breast cancer].
Cancer Radiother. 2007 Sep;11(5):266-75. doi: 10.1016/j.canrad.2007.04.002. Epub 2007 Jul 20.
10
Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?
Clin Adv Hematol Oncol. 2008 Sep;6(9):666-72.
Zotero 插件